Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World

Macintosh Laryngoscope Intubation Contact – Study

September 6, 2025 Lisa Park Tech

Okay, hereS the HTML article based on ⁢your ⁢detailed instructions. I’ve focused on creating a thorough, SEO-pleasant piece about the FDA approval of the first over-the-counter birth control pill, Opill. ​I’ve included the requested elements (at-a-glance,editor’s‌ analysis,tables,etc.) and adhered to the ⁤style guidelines. ‌ Because you indicated you are *not* a medical professional, the tone⁣ is geared towards a general audience, explaining the implications and context.

“`html

Opill: FDA Approves First over-the-Counter Birth Control Pill in US

Table of Contents

  • Opill: FDA Approves First over-the-Counter Birth Control Pill in US
    • What Happened?
    • Why This Matters: Expanding Access to Contraception
      • Opill: Key Facts
    • How Opill Works: A Progestin-Only Pill

A landmark decision expands access to contraception,potentially impacting millions of Americans.

July​ 13, 2023

What Happened?

On July ​13, 2023, the Food and Drug Management (FDA) approved Opill (norgestrel), a progestin-only birth ⁣control pill, for over-the-counter (OTC) sale​ in the United States.⁢ This marks the⁣ first time a daily birth control ⁢pill ⁣has been available without a⁤ prescription.The decision, made by the FDA’s Nonprescription Drugs Advisory Committee, ⁢followed⁢ years ‍of‍ advocacy from reproductive health organizations and pharmaceutical company HRA Pharma.

Image‍ of Opill packaging. Placeholder image used.
opill packaging.the pill‍ will be available in drugstores and‌ convenience stores.

The FDA determined that Opill‌ is safe and effective for use without the⁢ supervision of a⁢ healthcare provider. ‌ This approval relies ⁣on decades ‌of data⁤ demonstrating the safety of progestin-only pills⁢ and the ability of consumers to understand and follow the directions for use.

Why This Matters: Expanding Access to Contraception

The availability of OTC birth control pills is​ expected ⁤to considerably improve access to contraception, particularly for individuals ⁣who face barriers to accessing healthcare, such as those living‍ in rural ⁤areas, lacking insurance, or experiencing transportation challenges. According to the Guttmacher Institute, nearly 19.7 million women ‌of‍ reproductive age​ live in contraceptive deserts ​- areas with limited access to publicly funded family ⁢planning services.

Opill: Key Facts

  • What: First FDA-approved over-the-counter birth control pill.
  • Active Ingredient: Norgestrel (a progestin).
  • Approved: ‌ July 13, 2023
  • Manufacturer: HRA Pharma
  • Why it Matters: ‌Increases access to contraception, especially​ for those facing barriers to healthcare.
  • What’s Next: ​Expected to be available⁣ in drugstores and convenience stores in early 2024.

Progestin-only pills, like Opill, are generally considered safe for a wider range ​of individuals than combination‍ pills (containing both estrogen and progestin). They are often recommended for women who cannot take estrogen ⁣due to medical conditions⁣ like‌ migraines with aura or a history of blood clots.

How Opill Works: A Progestin-Only Pill

Opill contains only norgestrel, a synthetic ‌progestin hormone.‍ It primarily prevents pregnancy by thickening ‍the cervical‍ mucus, making it tough for sperm to reach the egg. it ​may also ⁢suppress ovulation, though this is less consistent than with combination pills.Unlike combination pills, Opill does not contain estrogen, wich means‍ it has⁣ fewer potential side‍ effects for some individuals.

Important Note: opill is most effective when taken at⁣ the same time every day. ⁢ It does not protect against sexually transmitted infections (stis). Condoms are still necessary ⁢for STI prevention.

Effectiveness ⁣(Typical Use) Effectiveness (Perfect Use)
91% 93%
Source: HRA Pharma​ data based on clinical trials. Effectiveness rates represent the percentage of women who do not

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service